MEDSIR

Last Friday, MEDSIR's office hosted a meeting for the #I3LUNG partners: Vall d'Hebron Institute of Oncology (VHIO), Universitätsklinikum Hamburg Eppendorf, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Istituto Mario Negri and MEDSIR, represented by Caterina Carbonell Núñez, Aina Bursá, Rocío Caro Consuegra, Ronald Simon, MELISSA FERNANDEZ PINTO, Alba Meya Molina, Ramon Amat Ferrer, Monica Ganzinelli, Laura Brunelli and Cecilia Silvestri.   During this working session, the team shared initial results from the first phase of patient analysis and conducted an in-depth brainstorming session focused on integrating innovative techniques to advance the project. They also discussed progress on the OMICs platform and established a timeline for potential results communications in 2025.   Go, go, GOOO #I3LUNG project 💙🫁 #I3LUNG #lungcancer #HorizonEurope #EuropeanCommission #EUFunded #EU4Health European Commission

Last week, the Data Analytics and Scientific Impact teams from MEDSIR organized their first retreat in Sevilla. This meeting not only offered an in-depth look at the impressive work each team carries out every day, but also provided an opportunity to share strengths, address challenges, identify areas for improvement, and explore what each team can contribute to the other. All this with the purpose of advancing cancer research through clinical trials.   Thank you so much to everyone for your constructive feedback over those two amazing days and for choosing Sevilla as the host city for this first retreat. Here you can see a group photo, which of course includes those who couldn’t attend in person ;)

Last week, the MEDSIR team had the opportunity to visit several hospitals across the United Kingdom, where several of our ongoing clinical trials are being conducted. These visits also enabled us to evaluate new hospitals to facilitate access to new therapeutic options for more patients. During this visit, we were delighted to meet with our esteemed Dr. Carles Escriu, Medical Oncologist at The Clatterbridge Cancer Centre NHS Foundation Trust, and Dr. Giuseppe Banna, Consultant Medical Oncologist at Portsmouth Hospitals University NHS Trust,  as well as to engage with the medical teams that support them in developing Investigator-Initiated Trials. At MEDSIR, we remain committed to fostering innovation in oncology and collaborating with experts worldwide to bring meaningful advancements to cancer research. #ClinicalTrials #OncologyResearch #IITs 🇪🇸 La semana pasada, el equipo de MEDSIR tuvo la oportunidad de visitar varios hospitales en el Reino Unido, donde se están llevando a cabo varios de nuestros ensayos clínicos en curso. Estas visitas también nos permitieron evaluar nuevos hospitales para facilitar el acceso a nuevas opciones terapéuticas para más pacientes.

It has been an incredible last couple of days here at the Nexus Conference in New Jersey! Connected with many amazing clinical & research professionals who are pushing the boundaries for Oncology patients! Our team at MEDSIR is at the forefront of Oncology research & capable of providing tailored solutions for your clinical projects! I look forward to staying in touch with everyone I connected with! Safe travels home!

Wrapping up the Nexus Conference - 21st BioPharma Clinical Trials! What an incredible opportunity to connect with sponsors and gain insights into their challenges in patient selection and recruitment. Danilo A. Belloso, Business Director at MEDSIR, emphasized the value of these past two days. Wishing everyone safe travels, and we look forward to seeing you soon! #ClinicalTrials #Biopharma #PharmaInnovation

MEDSIR leading the conversation at the Nexus Conference - 21st BioPharma Clinical Trials! During an insightful panel discussion, Rui Rui Zhang Xiang, Business Director, highlights on the evolving landscape of clinical trials across different regions. Addressing the unique challenges, she emphasized the need for innovation: "If we want to achieve different results, we must approach things differently. Today, we can’t run clinical trials the way we did in the past. We need to explore alternative approaches and adopt adaptive clinical trials to execute efficiently and optimize outcomes." Stay tuned for insights and key takeaways on #clinicaltrials ! #Biopharma #PharmaInnovation

Our exhibitors are in full swing at the Nexus Conference happening right now in Somerset, New Jersey! What a day – packed with brilliant insights, connections, and innovative breakthroughs! We’re thrilled to see the energy and excitement from everyone here. #BiopharmaInnovation #HealthcareLeadership #PharmaIndustry #InnovationInHealth #BiotechSolutions #SomersetNJ #NetworkingOpportunity #BiopharmaGrowth 😊

Good Morning from New Jersey! It's Day One at the Nexus Conference - 21st BioPharma Clinical Trials! What a fantastic opportunity to connect with leaders and innovators in the world of clinical trials. Today, we are excited to participate in the Panel Discussion on Running Clinical Trials in Different Geographic Regions: Assessing Opportunities and Challenges, featuring Rui Rui Zhang Xiang Business Director. Stay tuned for insights and key takeaways on overcoming the complexities of global trials! #ClinicalTrials #Biopharma #PharmaInnovation

Shaping the Future of Clinical Trials at the 21st BioPharma Clinical Trials Nexus! 🧬 Tomorrow, we gather at the Holiday Inn Piscataway, New Jersey, to celebrate a decade of driving alliances, collaboration, and innovation! 🌍✨ Our exhibitors, including MEDSIR's talented team – Rui Rui Zhang Xiang, Carles berloso cortés, and Danilo A. Belloso – will present breakthrough strategies and solutions that push the boundaries of clinical research. 🚀🔬 This is your opportunity to engage with thought leaders, discover new technologies, and explore transformative approaches that will shape the future of biopharma. Don't miss out on networking with the best in the industry and gaining insights that could redefine your clinical trials journey! 🏆🤝 #ClinicalTrials #BioPharma #NexusConference #LifeSciences #InnovateTogether #ClinicalResearch #PharmaCommunity #FutureOfBiotech #ResearchExcellence #BiopharmaLeadership 😊

On #WorldBreastCancerDay 🎗️, let’s come together to raise awareness, promote early detection, and provide heartfelt support to those who need it most. Breast cancer affects millions worldwide, making it one of the most prevalent cancers among women, but it can also impact men. It’s essential to educate younger generations about the risk factors and stress the importance of regular screenings—because prevention is our most powerful tool.   At MEDSIR, we are dedicated to conducting innovative research for all patients, with a focus on enhancing their quality of life, because they are always at the core of our mission. 🫂 #BreastCancerAwareness #CancerResearch 🇪🇸En el Día Mundial contra el Cáncer de Mama 🎗️, unámonos para aumentar la concienciación, promover la detección temprana y brindar un apoyo a quienes lo necesitan. En MEDSIR, estamos comprometidos a realizar estudios innovadores para todos los y las pacientes, siempre buscando su calidad de vida. 🫂